menu title
MWAETC On-Demand: HIV Treatment
-
Data on the newly approved medication Lenacapavir
-
Review of historic and recent data on cardiovascular risk
-
Review of studies on HIV prevention, treatment and co-morbidities…
-
-
When and how to initiate treatment and establish care for patients newly…
-
Update on treatment guidelines, new agents, and what's in the pipeline
-
Best practices for linking, engaging, and retaining youth with HIV (YWH)…
-
Review of HIV treatment studies presented at the CROI 2022 conference
-
The "how to" of using Cabotegravir/Rilpivirine in your clinic
-
Overview of the ART decision-making tool, ASSIST
-
How to integrate long-acting injectable ART into the clinical care setting
-
-
Update on 2021 DHHS HIV treatment guidelines
-
Interactions between ART medications for HIV and DAA medications for…
-
Dr. Landovitz discusses HPTN 083, an efficacy study of long-acting…
-
Overview of Fostemsavir, a recently approved attachment inhibitor
-
Update on 2019 DHHS gudielines on 2-Drug and other initial ART regimens
-
-
Update on 2019 DHHS treatment guidelines for adults and adolescents
-
2020 CROI highlights on Dual ART and HIV Cure progress
-
2020 CROI highlights on ART safety and side effects
-
Empty Subtitle Byline for this Presentation. Need to enter byline.
-
-
